These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Xiang ZQ, Yang Y, Wilson JM, Ertl HC. Virology; 1996 May 01; 219(1):220-7. PubMed ID: 8623532 [Abstract] [Full Text] [Related]
3. Canine adenovirus based rabies vaccines. Tordo N, Foumier A, Jallet C, Szelechowski M, Klonjkowski B, Eloit M. Dev Biol (Basel); 2008 May 01; 131():467-76. PubMed ID: 18634509 [Abstract] [Full Text] [Related]
4. Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier. Xiang ZQ, Gao GP, Reyes-Sandoval A, Li Y, Wilson JM, Ertl HC. J Virol; 2003 Oct 01; 77(20):10780-9. PubMed ID: 14512528 [Abstract] [Full Text] [Related]
5. Rabies DNA vaccination by the intranasal route in dogs. Tesoro Cruz E, Hernández González R, Alonso Morales R, Aguilar-Setién A. Dev Biol (Basel); 2006 Oct 01; 125():221-31. PubMed ID: 16878480 [Abstract] [Full Text] [Related]
6. Induction of genital immunity by DNA priming and intranasal booster immunization with a replication-defective adenoviral recombinant. Xiang ZQ, Pasquini S, Ertl HC. J Immunol; 1999 Jun 01; 162(11):6716-23. PubMed ID: 10352290 [Abstract] [Full Text] [Related]
8. Prime-boost immunization using alphavirus replicon and adenovirus vectored vaccines induces enhanced immune responses against classical swine fever virus in mice. Zhao HP, Sun JF, Li N, Sun Y, Wang Y, Qiu HJ. Vet Immunol Immunopathol; 2009 Oct 15; 131(3-4):158-66. PubMed ID: 19411115 [Abstract] [Full Text] [Related]
11. Single oral immunization with replication deficient recombinant adenovirus elicits long-lived transgene-specific cellular and humoral immune responses. Sharpe S, Fooks A, Lee J, Hayes K, Clegg C, Cranage M. Virology; 2002 Feb 15; 293(2):210-6. PubMed ID: 11886240 [Abstract] [Full Text] [Related]
12. Multiple alternating immunizations with DNA vaccine and replication incompetent adenovirus expressing gB of pseudorabies virus protect animals against lethal virus challenge. Kim SJ, Kim HK, Han YW, Aleyas AG, George JA, Yoon HA, Yoo DJ, Kim K, Eo SK. J Microbiol Biotechnol; 2008 Jul 15; 18(7):1326-34. PubMed ID: 18667863 [Abstract] [Full Text] [Related]
13. Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers. Pinto AR, Fitzgerald JC, Giles-Davis W, Gao GP, Wilson JM, Ertl HC. J Immunol; 2003 Dec 15; 171(12):6774-9. PubMed ID: 14662882 [Abstract] [Full Text] [Related]
14. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2. Patial S, Chaturvedi VK, Rai A, Saini M, Chandra R, Saini Y, Gupta PK. Vaccine; 2007 May 16; 25(20):4020-8. PubMed ID: 17391817 [Abstract] [Full Text] [Related]
15. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model. Suh YS, Park KS, Sauermann U, Franz M, Norley S, Wilfingseder D, Stoiber H, Fagrouch Z, Heeney J, Hunsmann G, Stahl-Hennig C, Sung YC. Vaccine; 2006 Mar 10; 24(11):1811-20. PubMed ID: 16274888 [Abstract] [Full Text] [Related]